Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07255443

Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital

significant benefits by providing data to improve infection control, guide early detection, and reduce CRE transmission in ICUs.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Rate of Carbapenemase Intestinal Carrier Inside ICU

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults (≥18 years)_
  • Expected ICU stay ≥48 hours -

Exclusion criteria

  • .ICU stay <48 hours

Treatment and study plan

observational study

Other

Observational study

Primary outcomes

  1. rate of intestinal colonization with CRE

    Time frame: One year

Sponsors and collaborators

Lead sponsor

Israa Ahmed abdelhalim

Other

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Dec 1, 2025
Registry last updated
Dec 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.